Innovation
1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 23 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |
Developing breakthrough treatments for asthma, organ transplant viability, and fibrosis
1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 23 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |